title: Modelling the evolution of genetic instability during tumour progression.
abstract: The role of genetic instability in driving carcinogenesis remains controversial. Genetic instability should accelerate carcinogenesis by increasing the rate of advantageous driver mutations; however, genetic instability can also potentially retard tumour growth by increasing the rate of deleterious mutation. As such, it is unclear whether genetically unstable clones would tend to be more selectively advantageous than their genetically stable counterparts within a growing tumour. Here, we show the circumstances where genetic instability evolves during tumour progression towards cancer. We employ a Wright-Fisher type model that describes the evolution of tumour subclones. Clones can acquire both advantageous and deleterious mutations, and mutator mutations that increase a cell's intrinsic mutation rate. Within the model, cancers evolve with a mutator phenotype when driver mutations bestow only moderate increases in fitness: very strong or weak selection for driver mutations suppresses the evolution of a mutator phenotype. Genetic instability occurs secondarily to selectively advantageous driver mutations. Deleterious mutations have relatively little effect on the evolution of genetic instability unless selection for additional driver mutations is very weak or if deleterious mutations are very common. Our model provides a framework for studying the evolution of genetic instability in tumour progression. Our analysis highlights the central role of selection in shaping patterns of mutation in carcinogenesis.
authors: Center for Evolution and Cancer, University of California San Francisco San Francisco, CA, USA.
authors: Ruchira
authors: R
authors: S Datta
authors: Alice
authors: A
authors: Gutteridge
authors: Charles
authors: C
authors: Swanton
authors: Carlo C
authors: CC
authors: Maley
authors: Trevor A
authors: TA
authors: Graham
keywords: carcinogenesis; clonal expansion; genetic instability; mathematical biology; selection
references: Cancer Res. 1999 Oct 15;59(20):5148-53
references: 10537290
references: Cancer Res. 2004 Oct 15;64(20):7629-33
references: 15492292
references: Nat Rev Cancer. 2011 Jun;11(6):450-7
references: 21593786
references: J R Soc Interface. 2008 Jan 6;5(18):105-21
references: 17580291
references: Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14140-5
references: 16966602
references: Annu Rev Pathol. 2011;6:479-507
references: 21090969
references: Nat Cell Biol. 2001 Apr;3(4):433-8
references: 11283620
references: Genetics. 2005 Dec;171(4):2123-31
references: 16143627
references: Nat Rev Cancer. 2003 Sep;3(9):695-701
references: 12951588
references: Cancer Res. 2010 Sep 1;70(17):6797-803
references: 20656803
references: Annu Rev Pathol. 2010;5:51-75
references: 19743960
references: PLoS One. 2009 Jun 10;4(6):e5860
references: 19517009
references: Trends Cell Biol. 1999 Dec;9(12):M57-60
references: 10611684
references: Cancer Res. 2011 May 15;71(10):3447-52
references: 21270108
references: Lancet Oncol. 2007 Nov;8(11):1030-8
references: 17976613
references: Nat Genet. 2006 Apr;38(4):468-73
references: 16565718
references: Genetics. 2011 Jun;188(2):461-77
references: 21406679
references: PLoS Comput Biol. 2007 Nov;3(11):e225
references: 17997597
references: Gut. 2008 Jul;57(7):941-50
references: 18364437
references: PLoS One. 2011;6(6):e21657
references: 21738754
references: N Engl J Med. 2012 Mar 8;366(10):883-892
references: 22397650
references: Artif Life. 2000 Fall;6(4):325-45
references: 11348585
references: Science. 2006 Oct 13;314(5797):268-74
references: 16959974
references: Proc Natl Acad Sci U S A. 2004 May 4;101(18):7017-21
references: 15105448
references: Nat Med. 1999 Jan;5(1):11-2
references: 9883827
references: Semin Cancer Biol. 2010 Oct;20(5):340-52
references: 20934514
references: Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2225-8
references: 10681434
references: New J Phys. 2011 Nov 1;13:
references: 22707911
references: Nature. 1997 Jun 12;387(6634):700-2
references: 9192893
references: Nature. 1997 Jun 12;387(6634):703-5
references: 9192894
references: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14800-3
references: 8962135
references: Cancer Res. 2011 Mar 1;71(5):1858-70
references: 21363922
references: Cancer Res. 2001 Apr 15;61(8):3230-9
references: 11309271
references: Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15095-100
references: 12415112
references: Nat Cell Biol. 2007 May;9(5):573-80
references: 17417627
references: Cancer Res. 2008 May 15;68(10):3558-60; discussion 3560-1
references: 18483234
references: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50
references: 20876136
references: N Engl J Med. 2009 Dec 17;361(25):2449-60
references: 20018966
references: Nature. 2009 Oct 29;461(7268):1243-7
references: 19838166
references: Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2183-94
references: 21784954